JUVENILE MYELOMONOCYTIC LEUKEMIA
Clinical trials for JUVENILE MYELOMONOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new JUVENILE MYELOMONOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for JUVENILE MYELOMONOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New stem cell method aims to cut transplant complications in blood cancer patients
Disease control Recruiting nowThis study tests a new way to prepare stem cells for transplant in children and adults with blood cancers like leukemia. The method removes certain immune cells to lower the risk of graft-versus-host disease, a serious side effect. About 70 participants will receive the treatment…
Matched conditions: JUVENILE MYELOMONOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated May 17, 2026 03:13 UTC
-
New immune cell boost may shield kids from infections after transplant
Disease control Recruiting nowThis study tests whether adding specially prepared donor immune cells can help children recover from stem cell transplants faster and avoid dangerous infections. Participants are children under 25 with high-risk blood cancers who have already received a transplant. The goal is to…
Matched conditions: JUVENILE MYELOMONOCYTIC LEUKEMIA
Phase: NA • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Immune cell boost shows promise for leukemia relapse after transplant
Disease control Recruiting nowThis early-phase study tests a new type of immune cell (CIML NK cells) combined with a low-dose drug (IL-2) in people whose leukemia or related blood cancers have returned after a stem cell transplant. The goal is to find a safe dose and see if it can put the cancer back into rem…
Matched conditions: JUVENILE MYELOMONOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
Engineered immune cells take aim at returning leukemia
Disease control Recruiting nowThis early-stage study tests a new treatment for children and adults with acute leukemia that has come back or not responded after a donor stem cell transplant. The treatment uses the patient's own immune cells (T cells) that are modified in a lab to recognize and attack a protei…
Matched conditions: JUVENILE MYELOMONOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
New study aims to sharpen diagnosis of rare childhood blood cancers
Knowledge-focused Recruiting nowThis study is for children and teens with rare blood cancers called MDS and JMML. The goal is to make diagnoses more accurate by using a standard set of tests and looking closely at genetic changes. Researchers will track survival and treatment outcomes. About 260 participants wi…
Matched conditions: JUVENILE MYELOMONOCYTIC LEUKEMIA
Sponsor: University Hospital Freiburg • Aim: Knowledge-focused
Last updated May 17, 2026 03:09 UTC
-
New screening trial aims to match kids with relapsed leukemia to better treatments
Knowledge-focused Recruiting nowThis study screens children and young adults (up to age 22) whose leukemia has returned or is difficult to treat. By testing their blood and bone marrow, doctors look for specific genetic markers to match them with the most promising experimental treatments. The goal is to improv…
Matched conditions: JUVENILE MYELOMONOCYTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: PedAL BCU, LLC • Aim: Knowledge-focused
Last updated May 04, 2026 16:30 UTC